IL6 and COVID-19: These, in association with our findings of KA effect on SARS-CoV-2 replication, are a combination that is particularly significant considering the pathogenesis of COVID-19, with the disease resulting in increased IL-6 and other inflammatory cytokines in the patients’ blood (Miranda et al., 2015; Cao and Li, 2020).